List view / Grid view
Filter the results
Scientists have developed a new method that accelerates the design and engineering of potential medicines and vaccines using glycosylation.
Researchers in Spain have achieved functional recovery from a stroke after implanting silk fibroin hydrogels-encapsulated stem cells in stroke mice.
Human eggs have been fully grown in a laboratory, in a move that could lead to improved fertility treatments...
Scientists in Denmark have made it possible to rank the risk of resistance genes and predict the evolution of existing and future drugs.
Researchers in Spain have developed a method of gene therapy that cures pulmonary fibrosis in mice by lengthening telomeres – the protective protein sections at the end of chromosomes.
Researchers from Canada try a new approach to eliminate dormant HIV-infected cells from the body using the MG1 virus.
The first data network for this research could also be the blueprint for similar data networks for research into other conditions...
In a collaboration between Swedish and Italian researchers, the aim was to analyse how the brain interprets information from a virtual experience of touch, created by a finger prosthesis with artificial sensation. The result was – completely unexpectedly – a new method for measuring brain health.
Researchers from UPM and CSIC have employed waste from the agri-food industry to develop biomaterials that are able to act as matrices to regenerate bone and cartilage tissues, which is of great interest for the treatment of diseases related to ageing.
Swedish researchers at Chalmers University of Technology and Sahlgrenska Academy have successfully induced human cartilage cells to live and grow in an animal model, using 3D bioprinting.
Although anti-inflammatory treatments are quite effective at reducing symptoms in patients with Crohn's disease and ulcerative colitis, the mucosal lining of the intestine often remains ulcerated, and many patients still ultimately require surgery.
Orion and Finland are both celebrating their centenaries in 2017.
The biotechnology company Genmab announced today the appointment of Judith Klimovsky, MD, as Executive Vice President and Chief Development Officer.
13 October 2015 | By Victoria White
Researchers have developed the first animal-free screening platforms capable of predicting the toxic effects of compounds on the human kidney accurately...